HEALTH PROFESSIONAL · SOURCE READING

Treatment Options for Thyrotropin-Producing Tumors

Source: Pituitary Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: December 17, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Thyrotropin-Producing Tumors

Treatment options for thyrotropin-producing tumors include:

Surgery (usually a transsphenoidal approach), with or without adjuvant radiation therapy.[1,2]

Source links and citations

Somatostatin analogues, such as octreotide.[3,4]

Source links and citations

Transsphenoidal surgery is the treatment of choice for patients with thyrotropic adenomas.[1] Adjuvant radiation therapy may be used when surgery is known to be noncurative, even if the patient is still euthyroid. This is because relapse is inevitable, and the full effect of radiation therapy requires months or years.

Source links and citations

Medical therapy may be required for patients who still have hyperthyroid symptoms despite surgery and external radiation. Somatostatin analogues are the treatment of choice, but their efficacy may wane with time.[1-4]

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice